Key Facts & Current Challenges
Pediatric Gram-negative sepsis remains a high-stakes clinical emergency where delays in obtaining reliable AST results can significantly impact outcomes. Conventional workflows often prolong time to targeted therapy, increasing the risk of inappropriate antimicrobial use and extended hospital stays. Rapid, accurate AST is therefore essential to overcoming these challenges and improving patient management.
What the Webinar Will Present
This webinar will showcase how the Bambino Gesù Children’s Hospital successfully implemented ASTar into routine practice as a rapid phenotypic AST solution for Gram-negative bloodstream infections. The session will also feature insights from the Clinical impact study, which evaluated the clinical and economic impact of integrating rapid AST into real-world pediatric sepsis pathways.
What the Audience Will Learn
Participants will gain an in-depth understanding of how rapid AST influences earlier therapeutic optimization, supports antimicrobial stewardship, and enhances decision-making in critical pediatric cases. The webinar will provide practical takeaways, including workflow integration strategies, real-world performance data, and evidence demonstrating how ASTar helps transform outcomes for children with Gram-negative sepsis.
Call to Action
Rapid, reliable AST is not just an improvement, it’s becoming essential to give septic children the timely, targeted care they need.
RegisterKey Learning Objectives
- Understand the clinical impact of rapid AST
- Evaluate real-world evidence from ASTar routine implementation
- Key clinical aspects in pediatric patient management
